Li Kang Biomedical Co (ROCO:6242) EV-to-FCF : 1,626.52 (As of Apr. 07, 2025)

Li Kang Biomedical Co EV-to-FCF Chart

Li Kang Biomedical Co Annual Data
	Trend	Dec15	Dec16	Dec17	Dec18	Dec19	Dec20	Dec21	Dec22	Dec23	Dec24
EV-to-FCF		Get a 7-Day Free Trial					8.25	13.18	6.92	15.16	1,553.57

Li Kang Biomedical Co Quarterly Data
	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24
EV-to-FCF	Get a 7-Day Free Trial															15.16	17.59	21.43	15.68	1,553.57

Competitive Comparison of Li Kang Biomedical Co's EV-to-FCF

For the Travel Services subindustry, Li Kang Biomedical Co's EV-to-FCF, along with its competitors' market caps and EV-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Li Kang Biomedical Co's EV-to-FCF Distribution in the Travel & Leisure Industry

For the Travel & Leisure industry and Consumer Cyclical sector, Li Kang Biomedical Co's EV-to-FCF distribution charts can be found below:

* The bar in red indicates where Li Kang Biomedical Co's EV-to-FCF falls into.

Li Kang Biomedical Co EV-to-FCF Calculation

Li Kang Biomedical Co's EV-to-FCF for today is calculated as:

Li Kang Biomedical Co's current Enterprise Value is NT$1,063.7 Mil.
Li Kang Biomedical Co's Free Cash Flow for the trailing twelve months (TTM) ended in Dec. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was NT$0.7 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Li Kang Biomedical Co  (ROCO:6242) EV-to-FCF Explanation

EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.

Li Kang Biomedical Co's PE Ratio (TTM) for today is calculated as:

Li Kang Biomedical Co's share price for today is NT$39.85.
Li Kang Biomedical Co's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was NT$2.460.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Free Cash Flow is an important financial metric because it represents the actual amount of cash at a company's disposal. Companies with a low EV-to-FCF ratio, combined with a strong balance sheet are generally considered as undervalued.

Li Kang Biomedical Co EV-to-FCF Related Terms

Thank you for viewing the detailed overview of Li Kang Biomedical Co's EV-to-FCF provided by GuruFocus.com. Please click on the following links to see related term pages.

Li Kang Biomedical Co Business Description